Anti-AU5 tag抗體,AU5 tag標簽抗體*產品產品詳細資料

產品編號 BYK-2113R

英文名稱 AU5 tag
中文名稱 AU5 tag標簽抗體
別    名 AU5 epitope tag; TDFYLK epitope tag; TDFYLK tag.
產品類型 標簽抗體 
研究領域 細胞類型標志物                             

抗體來源 Mouse or Rabbit

克隆類型 Monoclonal or Polyclonal
產品應用 WB、ELISA、IHC-P、IHC-F、Flow-Cyt、IF、IP、ICC 此產品應用不做依據，具體產品應用與實驗稀釋比請！

not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.

性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
亞    型 IgG
純化方法 affinity purified by Protein G
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.


     Anti-AU5 tag抗體,AU5 tag標簽抗體*產品產品介紹： 

      Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Plays an important role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Mediates apoptotic pathways throught association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptors-induced apoptosis remains controvertial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Secreted core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. May alter lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage.

 此相關標記有：Alexa Fluor 350 標記、Alexa Fluor 488 標記、Alexa Fluor 555 標記、Alexa Fluor 647 標記、AP標記、APC標記、Biotin標記、Cy3標記、Cy5標記、Cy5.5標記、Cy7標記、FITC標記、Gold標記、HRP標記、PE標記、PE-Cy3標記、PE-CY5標記、PE-CY5.5標記、PE-CY7標記、RBITC標記 

    相關產品：

     Anti-Histone H4(Acetyl K12),乙酰化組蛋白H4抗體

Anti-Histone H3(tri methyl K36),*基化組蛋白H3抗體
Anti-Histone H3(Di Methyl K36),二甲基化組蛋白H3抗體
Anti-Histone H2A/H2A.1抗體,組蛋白H2A抗體
Anti-Histone H2B(Acetyl K5),乙酰化組蛋白H2B抗體
Anti-HNF4A抗體,肝細胞核因子4α抗體
Anti-phospho-HNF4(Ser313),磷酸化肝細胞核因子4α抗體
Anti-Hamartin抗體,結節性硬化癥蛋白1抗體
Anti-HMGCS2抗體,三羥基*基*合成酶2抗體
Anti-HSD17B1抗體,羥類固醇脫氫酶17β-HSD抗體
Anti-HSD17B2抗體,羥類固醇脫氫酶17β2抗體
Anti-HSD11B1抗體,羥基類固醇脫氫酶11β1抗體
Anti-HSD3B1抗體,滋養層細胞抗原3β-HSD抗體
Anti-Hexokinase 1抗體,己糖激酶1抗體
Anti-Hexokinase 2抗體,己糖激酶2抗體
Anti-HPCL2抗體,植烷酰*羥化酶2抗體
Anti-HSD3B7抗體,滋養層細胞抗原3β7抗體
Anti-HADHA抗體,長鏈烯脂酰*脫氫酶抗體
Anti-HADHB抗體,羥*脫氫酶β抗體
Anti-HDL抗體,高密度脂蛋白抗體
Anti-HMGCL抗體,三羥基*基*裂解酶抗體
Anti-HMGCR抗體,三羥基*基*還原酶抗體
Anti-HMGCS1抗體,三羥基*基*合成酶1抗體